SINTX TechnologiesSINT +3.78%27 Gross Margin % is 21.33% as of Mar. 2026, which is 39% below its 10-year median of 34.91. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 85.71% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SINTX Technologies had a gross margin of 21.33% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SINTX Technologies Gross Margin % Related Terms
SINTX Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINT vs VVOS, AIDX, ALUR: Gross Margin % Comparison
For the Medical Devices subindustry, SINTX Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SINTX Technologies (SINT) has a Gross Margin % of 21.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on SINTX Technologies and its competitors. This is 39% below median its historical median of 34.91. Over the past decade, SINTX Technologies' Gross Margin % has ranged from 20.03 to 75.19. According to the industry distribution chart, SINTX Technologies ranks #690 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 85.7%.
Is SINTX Technologies' Gross Margin % too high?
SINTX Technologies' current Gross Margin % of 21.33% is 39% below median its 10-year median of 34.91. Over the past 10 years, this metric has ranged from a low of 20.03 to a high of 75.19. The Medical Devices & Instruments industry median Gross Margin % is 52.07. SINTX Technologies' value of 21.33% is 59% below this industry median. Based on the distribution chart, SINTX Technologies ranks #690 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Gross Margin % compare to VVOS and AIDX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #690 out of 805 companies for Gross Margin %. This places SINTX Technologies in the lower half of its industry. The industry median Gross Margin % is 52.07. SINTX Technologies' value of 21.33% is 59% below this benchmark. Historically, SINTX Technologies' own Gross Margin % has ranged from 20.03 to 75.19 over the past decade. While the company's 10-year median is 34.91 vs. the industry median of 52.07, SINTX Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SINTX Technologies's current Gross Margin % of 21.33% is 59% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current Gross Margin % is 21.33%, which is 39% below median its own 10-year median of 34.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.93 — trading 1186.7% above its estimated fair value. The current Gross Margin % is 21.33%, which is 39% below median its 10-year median of 34.91 and 59% below the Medical Devices & Instruments industry median of 52.07. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SINTX Technologies (SINT), the current Gross Margin % is 21.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.93 is trading 1186.7% above its estimated GF Value™ of $0.15.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
Gross Margin %: 21.33% (39% below median its 10-year median of 34.91)
GF Value™: $0.15 vs. price of $1.93 (1186.7% above fair value)
Industry Position: 59% below the Medical Devices & Instruments median (#690 of 805)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for SINT
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
